A Fiorentino1, C Chiumento, V Fusco. 1. Department of Radiation Oncology, IRCCS-CROB, Via S. Pio 1, 85028, Rionero in Vulture, PZ, Italy. albafiorentino@hotmail.it
Abstract
PURPOSE: To correlate comorbidity and acute radiation toxicity in elderly patients treated with adjuvant external beam radiotherapy (EBRT) plus brachytherapy-high dose rate (HDR-BRT) for endometrial cancer (EC). METHODS: Endometrial cancer patients over 65 were treated and evaluated for comorbidity assessment with ACE-27 and Charlson comorbidity index (CCI). EBRT total dose was 45-50.4 Gy (1.8 Gy/day). The vault vagina boost of dose was performed by HDR-BRT with 2/3 fractions with a total dose of 10-15 Gy. RESULTS: From 2008 to 2011, 35 patients were analyzed. Eighteen patients (51.43 %) had not ACE-27 comorbidity; while 27 patients (77.14 %) had CCI lower than three. During treatment, acute toxicity was mild and not influenced by the comorbidity score. Two-year Progression Free and Overall Survival were 69 and 80 %. ACE-27 and CCI did not affect progression-free survival (p = 0.51, p = 0.3) and OS (p = 0.26, p = 0.5). CONCLUSION: External beam radiotherapy plus BRT-HDR are well tolerated in EC elderly with good performance status and low comorbidity profile.
PURPOSE: To correlate comorbidity and acute radiation toxicity in elderly patients treated with adjuvant external beam radiotherapy (EBRT) plus brachytherapy-high dose rate (HDR-BRT) for endometrial cancer (EC). METHODS:Endometrial cancerpatients over 65 were treated and evaluated for comorbidity assessment with ACE-27 and Charlson comorbidity index (CCI). EBRT total dose was 45-50.4 Gy (1.8 Gy/day). The vault vagina boost of dose was performed by HDR-BRT with 2/3 fractions with a total dose of 10-15 Gy. RESULTS: From 2008 to 2011, 35 patients were analyzed. Eighteen patients (51.43 %) had not ACE-27 comorbidity; while 27 patients (77.14 %) had CCI lower than three. During treatment, acute toxicity was mild and not influenced by the comorbidity score. Two-year Progression Free and Overall Survival were 69 and 80 %. ACE-27 and CCI did not affect progression-free survival (p = 0.51, p = 0.3) and OS (p = 0.26, p = 0.5). CONCLUSION: External beam radiotherapy plus BRT-HDR are well tolerated in EC elderly with good performance status and low comorbidity profile.
Authors: Thomas T A Peters; Bernard F A M van der Laan; Boudewijn E C Plaat; Jan Wedman; Johannes A Langendijk; Gyorgy B Halmos Journal: Oral Oncol Date: 2010-12-15 Impact factor: 5.337
Authors: Mario Balducci; Alba Fiorentino; Pasquale De Bonis; Silvia Chiesa; Stefania Manfrida; Giuseppe Roberto D'Agostino; Giovanna Mantini; Vincenzo Frascino; Gian Carlo Mattiucci; Berardino De Bari; Annunziato Mangiola; Francesco Miccichè; Maria Antonietta Gambacorta; Gabriella Colicchio; Alessio Giuseppe Morganti; Carmelo Anile; Vincenzo Valentini Journal: Med Oncol Date: 2012-06-07 Impact factor: 3.064
Authors: F Fiorica; M Berretta; C Colosimo; S Berretta; M Ristagno; T Palmucci; S Palmucci; A Lleshi; S Ursino; R Fisichella; D Spartà; A Stefanelli; A Cappellani; U Tirelli; F Cartei Journal: Arch Gerontol Geriatr Date: 2009-12-30 Impact factor: 3.250
Authors: Jessica D Arden; Jonathan Dokter; Muayad F Almahariq; Kimberly Marvin; Sirisha R Nandalur; Zaid Al-Wahab; Jill Gadzinski; Barry Rosen; Maha Saada Jawad Journal: Adv Radiat Oncol Date: 2021-08-12